AJR AJR-based Continuing Ed for Technologists
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruhl, K. M.
Right arrow Articles by Spuentrup, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruhl, K. M.
Right arrow Articles by Spuentrup, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.07.2545
AJR 2008; 190:W360-W364
© American Roentgen Ray Society


Original Research

Time-Resolved 3D MR Angiography of the Foot at 3 T in Patients with Peripheral Arterial Disease

Karl M. Ruhl1, Marcus Katoh1,2, Stephan Langer3, Gottfried Mommertz3, Rolf W. Guenther1, Thoralf Niendorf1 and Elmar Spuentrup1

1 Department of Diagnostic Radiology, RWTH Aachen University, Pauwelsstrasse 30, 52057 Aachen, Germany.
2 Department of Radiology, University Hospital of the Saarland, Homburg/Saar, Germany.
3 Department of Vascular Surgery, RWTH Aachen University, Aachen, Germany.

Received May 10, 2007; accepted after revision December 14, 2007.

 
Address correspondence to K. M. Ruhl (karlruhl{at}gmx.net).

WEB This is a Web exclusive article.


Abstract
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
OBJECTIVE. The objective of our study was to prove the feasibility and clinical relevance of fast contrast-enhanced time-resolved 3D MR angiography (MRA) with submillimeter spatial resolution at a high magnetic field strength.

SUBJECTS AND METHODS. Twenty-one patients (five women, 16 men; mean age ± SD, 65 ± 14 years) were examined on a 3-T whole-body MR system with an 8-element phasedarray coil for preoperative evaluation of the pedal arterial system and assessment of the visualized vessels to serve as a graft touch-down site in pedal bypass surgery. Time-resolved 3D MRA of the foot was performed after automatic injection of 0.2 mmol/kg of gadobenate dimeglumine using a sagittal gradient-echo T1-weighted sequence (TR/TE, 4.2/1.6; flip angle, 30°; field of view, 290 mm; matrix, 352; 120 slices; slice thickness, 0.8 mm) with a spatial resolution of 0.8 x 0.8 x 1.6 mm reconstructed to 0.6 x 0.6 x 0.8 mm and a temporal resolution of 3.9 seconds using keyhole and sensitivity-encoding (SENSE) technology (SENSE factors: 4 in anteroposterior direction and 2 in right-left direction). Dynamic subtractions and rotating maximum intensity projections were calculated. The original image data sets were transferred to a dedicated workstation for objective signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) analysis of the arteries. Subjective image analysis regarding image quality and diagnostic findings was performed by two radiologists in consensus.

RESULTS. In all patients, images of diagnostic quality were obtained. Despite the known limitations regarding signal intensity measurements in images acquired with the use of parallel imaging technique, SNR and CNR proved to be excellent, with mean ± SD values of 294 ± 158 and 248 ± 144, respectively. Although most of the patients had diabetic foot syndrome with arteriovenous shunting, the arteries and the potential vessel for bypassing could be clearly separated from the veins in each case due to the temporal information given by our study. The ability to reliably discriminate arteries from veins is of high clinical relevance in planning pedal bypass surgery.

CONCLUSION. Fast contrast-enhanced time-resolved 3D MRA of the foot at 3 T is feasible and of high clinical value for the preoperative evaluation of the arterial supply of the foot.

Keywords: contrast-induced nephropathy • dorsalis pedis bypass • MR angiography • parallel imaging • pedal arteries • peripheral arterial disease • vascular imaging


Introduction
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
In patients with arterial occlusive disease, bypass surgery is the most important therapeutic option for preservation of the lower extremity, especially if the patient suffers from diabetes mellitus. The dorsalis pedis bypass is considered durable with a high likelihood of ischemic foot salvage over many years [1]. Before surgery, the vascular surgeon needs a diagnostic angiogram to determine the appropriate artery to anastomose. Intraarterial digital subtraction angiography (DSA) has traditionally been used for this purpose. Although by today's practice standard DSA is a relatively safe procedure, complications have been reported, including hemorrhage, dissection, or arterial embolism. Furthermore, the necessary use of iodinated contrast material may further impair the renal function in patients with diabetic nephropathy. In contrast, MR angiography (MRA) is noninvasive and avoids the use of iodinated contrast material and exposure to ionizing radiation. Contrast-enhanced MRA has evolved to be a safe, fast, reproducible, and reliable imaging technique [2].

Advances in MR hardware and fast data acquisition techniques, such as parallel imaging or advanced k-space filling schemes, make it possible to complete a whole 3D data set in a few seconds [3, 4]. This capability allows both high spatial resolution and high temporal resolution while achieving large volume coverage. In this prospective clinical study, we evaluated the potential of submillimeter in-plane spatial resolution contrast-enhanced time-resolved 3D MRA at a high magnetic field strength of 3 T for preoperative evaluation of the pedal vasculature in patients with diabetes, peripheral arterial disease (PAD), or both.


Figure 1
View larger version (47K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1 Maximum intensity projections of time-resolved 3D MR angiography after background subtraction in 64-year-old man with peripheral arterial disease, Fontaine stage IIb, show markedly delayed contrast inflow. Venous system is not enhanced yet.

 

Subjects and Methods
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
Subjects
Twenty-one patients (five women, 16 men; mean age ± SD, 65 ± 14 years) were enrolled in this prospective clinical study. Twenty patients suffered from PAD Fontaine stages IIb-IV with 70% of the cases (14 of 20) being classified as critical limb ischemia (Fontaine stages III and IV). Thirteen patients, in addition, had diabetes. One woman with Raynaud's phenomenon was referred to MRA. Two patients were examined before and after bypass surgery, and in one patient, both feet were examined (1 week apart), accounting for a total of 24 time-resolved 3D MRA examinations of the foot in this study.

MRI
Examinations were performed on a 3-T MR system (Achieva, Philips Medical Systems). The patients were examined in the supine position with one foot placed in a commercial cylindrically shaped 8-element phased-array radiofrequency coil (SENSE head, MRI Devices) for signal reception. The foot was positioned in slight plantar flexion and immobilized with foam padding.

Localization and Coil Sensitivity Calibration
Localization was performed using a gradient-echo sequence (TR/TE, 6.7/1.3; flip angle, 50°; field of view [FOV], 300 x 300 mm; matrix size, 256 x 256 pixel elements; three perpendicular stacks in sagittal, coronal, and axial orientations; scanning duration, 8 seconds). An extra reference scan was obtained to determine the coil sensitivity profiles (4.0/0.8; flip angle, 1°; FOV, 300 x 300 mm; matrix, 64 x 64).

Time-Resolved 3D MRA (4D MRA)
MRA images were acquired in a sagittal plane using a 3D gradient-echo T1-weighted sequence with the following parameters: 4.2/1.6; flip angle, 30°; rectangular FOV, 290 x 290 mm; matrix size, 352 x 352 reconstructed to 512 x 512; 120 slices; spatial resolution, 0.8 x 0.8 x 1.6 mm reconstructed to 0.6 x 0.6 x 0.8 mm. To achieve a temporal resolution of 3.9 seconds per dynamic scan, 2D sensitivity-encoding (SENSE)-based parallel imaging was performed using a net acceleration factor (R) of 8 (R = 4 along the anteroposterior direction and R = 2 in the right-left orientation) [5]. To further accelerate time-resolved 3D MRA, parallel imaging was supplemented by the half-Fourier technique and keyhole imaging (25%) in conjunction with centrally ordered k-space sampling (termed "contrast-enhanced time robust angiograph" [CENTRA]) [6-8]. Centrally ordered k-space sampling was applied to enhance image contrast in contrast-enhanced MRA (CE-MRA). For every patient, 16 dynamic scans, each with a 3.9-second temporal resolution, were obtained to cover both arterial and venous phases of the contrast agent passage through the pedal vessels. This was followed by a fully sampled reference scan mandatory for the keyhole approach, accounting for an overall scanning duration of 75 seconds (3.9 seconds for each dynamic scan and 16.5 seconds for the last dynamic scan including the reference image).

Paramagnetic contrast agent (0.5 mmol/L of gadobenate dimeglumine [MultiHance, Bracco]) [9] was injected automatically (Spectris Solaris EP MR Injection System, Medrad) through a peripheral catheter placed in an antecubital vein. A dose of 0.2 mmol/kg of body weight was injected with a flow rate of 3.0 mL/s followed by a 30-mL saline flush at the same flow rate. Data acquisition was started manually 10 seconds after the beginning of contrast injection to ensure at least one unenhanced dynamic scan was obtained for dynamic subtraction. Rotated dynamic maxi mum intensity projections were rendered over a 180° sector with 20 reconstructions from the subtracted images. Interpretation of the images was based on both the original data set and the maximum-intensity-projection images.

The images were transferred to a dedicated workstation (View Forum, Philips Medical Systems) and to a PACS (Sectra PACS, Sectra Imtec AB). Two radiologists read the images in consensus regarding good image quality with sharply delineated pedal vessels, differentiation between arteries and veins, presence of arterio venous shunting with early venous drainage, and pronounced soft-tissue enhancement [10]. Further more, the data sets were analyzed regard ing whether a temporal resolution of 3.9 seconds, as given in this study, was necessary or whether a temporal resolution of 7.8 seconds (2 x 3.9 seconds) would have been suitable to obtain the same diagnostic outcome.

The mean time between the peak arterial enhancement and the peak venous enhance ment was calculated in 11 MRA data sets. The other 13 data sets could not be analyzed in that respect because either the peak venous enhancement was not reached reliably until the last dynamic scan (eight of 24 data sets) or no venous filling was observed during the scanning time (five of 24 data sets) (Fig. 1). For further objective image analysis, regions of interest (ROIs) were placed in the original data sets to measure signal intensity in either the dorsal pedal artery or the posterior tibial artery (SIart) and in a pedal vein (SIven) in every dynamic scan, in the muscle (SImusc), and in the surrounding air (SIair). Signal-to-noise ratios (SNRs) were calculated for the dynamic scan showing the highest signal intensity in the vessel with the following equation:

Formula
where SIROI is the signal intensity in the ROI and SDair is the SD of the signal intensity given by the ROI in extracorporeal air. Artery- and vein-muscle CNRs (CNRart-musc and CNRven-musc, respectively) were calculated as follows:

Formula


Results
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
MRA was successfully performed in all patients and was well tolerated by all patients. In all patients, images of good diagnostic quality were obtained. Neither image-degrading SENSE nor motion artifacts were observed. Our results show that the arteries and the potential vessel to be used for bypassing could be clearly separated from the veins due to the temporal resolution given by our approach—even in patients who suffered from diabetic foot syndrome with arteriovenous shunting. In 14 of 24 (58%) MR angiography examinations, a temporal resolution of 3.9 seconds as implemented in this study was found to be essential for the evaluation of the small peripheral arteries. In the remaining 10 MR angiography examinations, a temporal resolution of 7.8 seconds would have been suitable for a reliable diagnosis (Fig. 1).


Figure 2
View larger version (10K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2 Arterial ({diamondsuit}) and venous ({blacksquare}) signal intensity curves over time in 70-year-old man with peripheral arterial disease, Fontaine stage IV, and diabetes.

 


Figure 3
View larger version (49K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3 Maximum intensity projections show early venous filling in 70-year-old man with diabetes mellitus and peripheral arterial disease, Fontaine stage IV. Note soft-tissue enhancement in forefoot region.

 
The mean time between peak arterial enhancement and peak venous enhancement was 24 seconds (SD = 13 seconds). Signal intensity-time curves were calculated for the arterial enhancement and venous enhancement for each patient, as illustrated in Figure 2. A subjective examination of the images, performed by two experienced radiologists, revealed early venous filling for 15 of the 24 MR angiography studies. In diabetic patients, early venous enhancement resulting from arteriovenous shunting was detected in 80% of the data sets (12 of 15) (Fig. 3).

The pedal arch proved to be patent in 22 of the 24 angiography studies. In the remaining two angiography examinations, the pedal arch was not displayed, although the main supplying arteries of the foot were clearly visible and delineated. In one patient, we found that the pedal arch was missed because of the tremendously delayed arrival of contrast medium in the target area (first arterial enhancement in the foot was observed at approximately 55 seconds after contrast agent injection). In the other patient, both the dorsal artery of the foot and the posterior tibial artery were occluded proximal to the pedal arch.

In every patient, both anterior and posterior circulations or one of the circulation systems of the foot could be evaluated due to occlusion of its counterpart. The posterior circulation was patent in 20 of the 24 MR angiography examinations, whereas the anterior circulation could be identified in 14 of the 24 examinations.

Pronounced soft-tissue enhancement could be visualized in 17 MR angiography studies [10]. The most common locations for soft-tissue enhancement were the forefoot (10 cases), the heel (nine cases), and toes (eight cases) (Figs. 3 and 4).


Figure 4
View larger version (38K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4 Maximum intensity projections show pronounced soft-tissue enhancement in toes and forefoot region in 66-year-old woman with diabetes mellitus and peripheral arterial disease, Fontaine stage IV. Posterior tibial artery is occluded. Pedal arch is via anterior circulation system.

 
The speed gain of parallel imaging is accompanied by SNR losses, as given by the following equation:

Formula
where SNRpMRI is the SNR obtained with parallel imaging; SNRbase, the baseline SNR without the use of parallel imaging; R, the acceleration factor; and g, the geometry factor that describes noise amplification associated with parallel imaging. The geometry factor is affected by the order of k-space sampling, the chosen reconstruction method, and the design of the radiofrequency coil used for signal reception [5]. The noise background is generally nonuniform in SENSE-based parallel imaging because the g factor varies spatially across both the image plane and 3D slab. Peaks in the g-factor map correspond to areas of increased noise and, hence, to areas of decreased SNR in the images. Taking this constraint aside, rough estimates of the SNR and CNR measured in the peak arterial phase proved to be excellent with a mean ± SD value for SNR of 294 ± 158 and for CNR of 248 ± 144. SNR measurements in the peak venous phase showed an SNR of 267 ± 96 and a CNR of 217 ± 84.


Discussion
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
CE-MRA is of proven value for the evaluation of the vasculature of the lower extremity because it is minimally invasive, safe, fast, and accurate and does not require the use of ionizing radiation and iodinated contrast medium, which is of paramount importance in diabetic patients with a high incidence of contrast-induced nephropathy of 5.7-29.4% [11]. However, recently the U.S. Food and Drug Administration (FDA) [12] issued a warning about gadolinium-containing contrast agents because the agency received 69 case reports of patients with moderate- to end-stage renal disease who underwent MRI or MRA and developed nephrogenic systemic fibrosis or nephrogenic fibrosing dermopathy. This warning stresses the need for the responsible use of gadolinium-containing contrast agents in patients with renal insufficiency.

As new therapeutic, especially surgical, options for the therapy of the diabetic foot emerge, the radiologist is expected to provide an accurate preoperative angiogram of the foot even in the presence of severe macroangiopathic changes and impaired renal function. MRA can provide high-quality images in this setting using the described technique. Postoperatively, MRA can be used to prove the patency of the bypass graft and to document improved perfusion of the foot (Fig. 5). Most previous studies have focused on high-resolution MRA of the foot [13]. Some authors also have described the time-resolved approach for MRA of the lower leg or foot at 1.5 T with a temporal resolution of between 6 and 25 seconds but with limited spatial resolution [10, 14]. However, CE-MRA of the foot requires high spatial resolution and high temporal resolution. High spatial resolution is mandatory to provide details about the vascular anatomy, which becomes key in target areas occupied by vessels with small diameters. High temporal resolution ensures that at least one acquisition coincides with the desired arterial bolus phase and enables separation of arteries from veins. Furthermore, high-temporal-resolution images provide information about flow dynamics [15].


Figure 5
View larger version (86K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 5 Time-resolved 3D MR angiography images of 70-year-old man with diabetes mellitus and peripheral arterial disease, Fontaine stage IV, obtained before (left) and after (right) surgery. Postoperative MR angiography image shows bypass graft anastomosed with dorsal pedal artery.

 

In this study, we approached the challenge of combining submillimeter in-plane spatial resolution with whole-target-organ coverage while achieving a temporal resolution of 3.9 seconds, which was enabled by the synergy of a keyhole-based time-resolved sampling strategy, half-Fourier imaging, elliptic-centric phase encoding, and 2D SENSE-based parallel imaging.

Eliminating the background signal via subtraction facilitates clear visualization of the enhanced vascular lumen. Investigators have also found that this approach enables visualization of small distal vessels, especially in regions where high fat signals are prevalent, as given in the foot [14]. Therefore, background subtraction is essential for a reliable diagnostic evaluation of pedal vasculature. The main disadvantage of subtraction techniques is susceptibility to motion, which may result in blurring; therefore, this disadvantage stresses the need for fixation of the foot in the coil to be adequate for imaging but not painful for the patient. For this purpose, we used elastic foam padding, which was tolerated well by the patients.

In a number of studies, investigators have proven the feasibility of CE-MRA of the foot at 1.5 T [10, 16], reporting its higher confidence and better quality when compared with 2D time-of-flight angiography [14] and even its supremacy over DSA [13], particularly because higher intraluminal contrast is needed in DSA, especially in patients with stenoses of the lower leg arteries. DSA in combination with standard angiography may fail to reveal patent arteries or vessel segments that are suitable for distal bypass grafting in patients with severe arterial occlusive disease [13].

At 3 T, mostly neurovascular imaging has been clinically implemented to date [17, 18]. Renal MRA at 3 T has been proven feasible for high-spatial-resolution 3D MRA [19]. To our knowledge, this study is the first to prove the feasibility of fast contrast-enhanced time-resolved 3D MRA of the foot with submillimeter spatial resolution at 3 T.

The ability to reliably discriminate arteries from veins is of high clinical relevance in planning pedal bypass surgery. In our protocol, this distinction was possible without restrictions in any case. Anterior and posterior circulations and the patency of the pedal arch could be evaluated in every patient. The key information needed before vascular surgery, which includes patency of the pedal arch, documentation of the presence and degree of collateral pathways, and accurate depiction of target vessels suitable for surgical bypass [16], were all provided by our study.

In 10 patients, either the peak venous enhancement was not reached or no venous filling at all could be visualized during 62.4 seconds for 16 dynamic scans. This is due to current hardware and MR system design constraints—that is, the maximum number of dynamic scans is limited by an intrinsic limitation of the reconstruction memory capacity, so the imaging protocol used in this study supports a maximum number of 16 dynamic scans. To overcome this constraint, 64-bit-based reconstruction hardware needs to be made clinically available, which will help to further foster the clinical potential of highly accelerated 3D CE-MRA for the venous drainage evaluation. Many element coil arrays, together with many receiver channels [20], may provide clinical options to further improve both temporal and spatial resolution.


References
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 

  1. Pomposelli FB, Kansal N, Hamdan AD, et al. A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases. J Vasc Surg 2003;37 : 307-315[CrossRef][Medline]
  2. Bezooijen R, van den Bosch HC, Tielbeek AV, et al. Peripheral arterial disease: sensitivity-encoded multiposition MR angiography compared with intraarterial angiography and conventional multiposition MR angiography. Radiology 2004;231 : 263-271[Abstract/Free Full Text]
  3. Katoh M, Bücker A, Mühlenbruch G, Schauerte P, Günther RW, Spuentrup E. Impact of ECG gating in contrast-enhanced MR angiography for the assessment of the pulmonary veins and the left atrium anatomy. Rofo 2006;178 : 180-184[Medline]
  4. Sodickson DK, Hardy CJ, Zhu Y, et al. Rapid volumetric MRI using parallel imaging with order-of-magnitude accelerations and a 32-element RF coil array: feasibility and implications. Acad Radiol2005; 12:626 -635[CrossRef][Medline]
  5. Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P. SENSE: sensitivity encoding for fast MRI. Magn Reson Med1999; 42:952 -962[CrossRef][Medline]
  6. Korperich H, Gieseke J, Esdorn H, et al. Ultrafast time-resolved contrast-enhanced 3D pulmonary venous cardiovascular magnetic resonance angiography using SENSE combined with CENTRA-keyhole. J Cardiovasc Magn Reson 2007; 9:77 -87[CrossRef][Medline]
  7. van Vaals JJ, Brummer ME, Dixon WT, et al. "Keyhole" method for accelerating imaging of contrast agent uptake. J Magn Reson Imaging 1993; 3:671 -675[Medline]
  8. Walter C, Philippi G, Westerhausen R, Kooijman H, Hoffmann HG, Busch HP. High resolution contrast-enhanced 3D MR-angiography of renal arteries using parallel imaging (SENSE) [in German]. Rofo 2003; 175:1244 -1250[Medline]
  9. Douek PC. MultiHance in MRA of peripheral vasculature. Eur Radiol 2004; 14[suppl 7]: O55-O60[CrossRef][Medline]
  10. Zhang HL, Kent KC, Bush HL, et al. Soft tissue enhancement on time-resolved peripheral magnetic resonance angiography. J Magn Reson Imaging 2004; 19:590 -597[CrossRef][Medline]
  11. Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl2006; 100:S11 -S15[Medline]
  12. United States Food and Drug Administration Website. Public Health Advisory. Gadolinium-containing contrast agents for magnetic resonance imaging (MRI): Omniscan, OptiMARK, Magnevist, ProHance, and MultiHance. www.fda.gov/cder/drug/advisory/gadolinium_agents.htm. June 8, 2006; updated May 23, 2007. Accessed March 27, 2008
  13. Kreitner KF, Kalden P, Neufang A, et al. Diabetes and peripheral arterial occlusive disease: prospective comparison of contrast-enhanced three-dimensional MR angiography with conventional digital subtraction angiography. AJR 2000;174 : 171-179[Abstract/Free Full Text]
  14. Sharafuddin MJ, Stolpen AH, Sun S, et al. High-resolution multiphase contrast-enhanced three-dimensional MR angiography compared with two-dimensional time-of-flight MR angiography for the identification of pedal vessels. J Vasc Interv Radiol 2002;13 : 695-702[Medline]
  15. Wu Y, Goodrich KC, Buswell HR, Katzman GL, Parker DL. High-resolution time-resolved contrast-enhanced 3D MRA by combining SENSE with keyhole and SLAM strategies. Magn Reson Imaging2004; 22:1161 -1168[CrossRef][Medline]
  16. Chomel S, Douek P, Moulin P, Vaudoux M, Marchand B. Contrast-enhanced MR angiography of the foot: anatomy and clinical application in patients with diabetes. AJR 2004;182 : 1435-1442[Free Full Text]
  17. Frydrychowicz A, Bley TA, Winterer JT, et al. Accelerated time-resolved 3D contrast-enhanced MR angiography at 3T: clinical experience in 31 patients. MAGMA 2006;19 : 187-195[CrossRef][Medline]
  18. Cashen TA, Carr JC, Shin W, et al. Intracranial time-resolved contrast-enhanced MR angiography at 3T. Am J Neuroradiol 2006; 27:822 -829[Abstract/Free Full Text]
  19. Michaely HJ, Nael K, Schoenberg SO, et al. The feasibility of spatial high-resolution magnetic resonance angiography (MRA) of the renal arteries at 3.0 T. Rofo 2005;177 : 800-804[Medline]
  20. Niendorf T, Sodickson D. Acceleration of cardiovascular MRI using parallel imaging: basic principles, practical considerations, clinical applications and future directions [in German]. Rofo2006; 178:15 -30[Medline]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruhl, K. M.
Right arrow Articles by Spuentrup, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruhl, K. M.
Right arrow Articles by Spuentrup, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS